
uhhospitals.org
Jul 18, 2025, 18:46
Akhil Santhosh: OrigAMI1 – The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“OrigAMI1: effect of Amivantamab in previously treated RAS wild colon cancer: encouraging outcomes in patients with a good prior response to EGFRi and longer time since prior EGFRi therapy.”
More posts featuring Akhil Santhosh.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 18, 2025, 18:18
Jul 18, 2025, 18:08
Jul 18, 2025, 17:19
Jul 18, 2025, 17:01
Jul 18, 2025, 16:52